uric acid has been researched along with Hemolysis, Elevated Liver Enzymes, Lowered Platelets in 11 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study is to determine the accuracy and clinical value of serum uric acid in predicting maternal complications in women with pre-eclampsia." | 8.85 | Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. ( Aarnoudse, JG; Groen, H; Koopmans, CM; Mol, BW; van den Berg, PP; van Pampus, MG, 2009) |
| "To determine the accuracy with which serum uric acid predicts maternal and fetal complications in women with pre-eclampsia." | 8.83 | Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. ( Coomarasamy, A; Ismail, KM; Khan, KS; Sharp, S; Thangaratinam, S, 2006) |
| "Serum uric acid levels and protein excretion in women that develop eclampsia." | 7.91 | Increased proteinuria and uric acid levels are associated with eclamptic crisis. ( Antonello, IC; da Cunha Filho, EV; Hentschke, MR; Luz, JH; Paula, LG; Pinheiro da Costa, BE; Poli-de-Figueiredo, CE, 2019) |
| "Hyperhomocysteinemia is a risk factor in obstetrical complications such as pre-eclampsia, 'hemolysis, elevated liver enzymes, low platelet' (HELLP)-syndrome and placental insufficiency." | 7.72 | Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency. ( Geisel, J; Herrmann, W; Hübner, U; Koch, I; Obeid, R; Retzke, U, 2004) |
| "The aim of this study is to determine the accuracy and clinical value of serum uric acid in predicting maternal complications in women with pre-eclampsia." | 4.85 | Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. ( Aarnoudse, JG; Groen, H; Koopmans, CM; Mol, BW; van den Berg, PP; van Pampus, MG, 2009) |
| "To determine the accuracy with which serum uric acid predicts maternal and fetal complications in women with pre-eclampsia." | 4.83 | Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. ( Coomarasamy, A; Ismail, KM; Khan, KS; Sharp, S; Thangaratinam, S, 2006) |
| "Serum uric acid levels and protein excretion in women that develop eclampsia." | 3.91 | Increased proteinuria and uric acid levels are associated with eclamptic crisis. ( Antonello, IC; da Cunha Filho, EV; Hentschke, MR; Luz, JH; Paula, LG; Pinheiro da Costa, BE; Poli-de-Figueiredo, CE, 2019) |
| " Significant changes of biochemical parameters in cases of hypertensive disorders in pregnancy are increased levels of blood glucose, urea, creatinine, uric acid (hyperuricemia), transaminases, and LDH." | 3.79 | Correlation of biochemical parameters and neonatal outcome in patients with gestational hypertension. ( Aksam, S; Kocijancic, A; Kocijancic, DM; Plecas, D; Plesinac, S, 2013) |
| "Hyperhomocysteinemia is a risk factor in obstetrical complications such as pre-eclampsia, 'hemolysis, elevated liver enzymes, low platelet' (HELLP)-syndrome and placental insufficiency." | 3.72 | Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency. ( Geisel, J; Herrmann, W; Hübner, U; Koch, I; Obeid, R; Retzke, U, 2004) |
| " Their serum uric acid levels were correlated with the development of HELLP syndrome, severity of hypertension, and incidence of SGA newborns (< 10th percentile birth weight)." | 3.71 | The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies. ( Galerneau, F; Williams, KP, 2002) |
| "The presence of nausea and vomiting, epigastric pain, or both in association with admission laboratory values that are in excess of the cutoffs for lactate dehydrogenase, aspartate aminotransferase, and uric acid concentrations or for all 6 tests is predictive of high risk of morbidity for the patient with severe preeclampsia." | 3.70 | Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. ( Blake, PG; Magann, EF; Martin, JN; May, WL; Rinehart, BK; Terrone, DA, 1999) |
| "Twenty-six transfusions (5." | 1.33 | Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. ( Codaccioni, X; Coudoux, E; Deruelle, P; Ego, A; Houfflin-Debarge, V; Subtil, D, 2006) |
| "To determine whether a rat model of preeclampsia includes features consistent with HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome." | 1.32 | Evaluation of a rat model of preeclampsia for HELLP syndrome characteristics. ( Bennett, WA; Cockrell, KL; Granger, JP; Isler, CM; Martin, JN; Morrison, JC; Rinewalt, AN, 2003) |
| "Class 3 HELLP syndrome is considered a clinically significant transitional group." | 1.30 | The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. ( Blake, PG; Magann, EF; Martin, JN; May, WL; Rinehart, BK; Terrone, DA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paula, LG | 1 |
| Pinheiro da Costa, BE | 1 |
| Hentschke, MR | 1 |
| Antonello, IC | 1 |
| Luz, JH | 1 |
| da Cunha Filho, EV | 1 |
| Poli-de-Figueiredo, CE | 1 |
| Koopmans, CM | 1 |
| van Pampus, MG | 1 |
| Groen, H | 1 |
| Aarnoudse, JG | 1 |
| van den Berg, PP | 1 |
| Mol, BW | 1 |
| Kocijancic, DM | 1 |
| Plesinac, S | 1 |
| Plecas, D | 1 |
| Aksam, S | 1 |
| Kocijancic, A | 1 |
| Williams, KP | 1 |
| Galerneau, F | 1 |
| Isler, CM | 1 |
| Bennett, WA | 1 |
| Rinewalt, AN | 1 |
| Cockrell, KL | 1 |
| Martin, JN | 3 |
| Morrison, JC | 1 |
| Granger, JP | 1 |
| Herrmann, W | 1 |
| Hübner, U | 1 |
| Koch, I | 1 |
| Obeid, R | 1 |
| Retzke, U | 1 |
| Geisel, J | 1 |
| Deruelle, P | 1 |
| Coudoux, E | 1 |
| Ego, A | 1 |
| Houfflin-Debarge, V | 1 |
| Codaccioni, X | 1 |
| Subtil, D | 1 |
| Thangaratinam, S | 1 |
| Ismail, KM | 1 |
| Sharp, S | 1 |
| Coomarasamy, A | 1 |
| Khan, KS | 1 |
| Izumi, A | 1 |
| Minakami, H | 1 |
| Matsubara, S | 1 |
| Sato, I | 1 |
| Rinehart, BK | 2 |
| May, WL | 2 |
| Magann, EF | 2 |
| Terrone, DA | 2 |
| Blake, PG | 2 |
2 reviews available for uric acid and Hemolysis, Elevated Liver Enzymes, Lowered Platelets
| Article | Year |
|---|---|
Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis.
Topics: Decision Support Techniques; Female; HELLP Syndrome; Humans; Labor, Induced; Pre-Eclampsia; Predicti | 2009 |
Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.
Topics: Biomarkers; Cesarean Section; Female; Fetal Growth Retardation; HELLP Syndrome; Humans; Hypertension | 2006 |
9 other studies available for uric acid and Hemolysis, Elevated Liver Enzymes, Lowered Platelets
| Article | Year |
|---|---|
Increased proteinuria and uric acid levels are associated with eclamptic crisis.
Topics: Adult; Biomarkers; Chi-Square Distribution; Creatinine; Disease Progression; Eclampsia; Female; HELL | 2019 |
Correlation of biochemical parameters and neonatal outcome in patients with gestational hypertension.
Topics: Apgar Score; Blood Glucose; Case-Control Studies; Creatinine; Female; HELLP Syndrome; Humans; Hypert | 2013 |
The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies.
Topics: Biomarkers; Case-Control Studies; Female; Fetal Growth Retardation; HELLP Syndrome; Humans; Infant, | 2002 |
Evaluation of a rat model of preeclampsia for HELLP syndrome characteristics.
Topics: Animals; Aorta; Arteries; Blood Cell Count; Blood Pressure; Constriction; Creatinine; Disease Models | 2003 |
Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency.
Topics: Cystathionine; Cystatin C; Cystatins; Female; Folic Acid; HELLP Syndrome; Homocysteine; Humans; Hype | 2004 |
Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies.
Topics: Abscess; Adult; Ascites; Cesarean Section; Creatinine; Disseminated Intravascular Coagulation; Femal | 2006 |
Triplet pregnancy complicated by a gradual decline in antithrombin-III activity and HELLP syndrome: a case report.
Topics: Adult; Alanine Transaminase; Antithrombin III; Cesarean Section; Female; Fertilization in Vitro; Hap | 1998 |
The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification.
Topics: Aspartate Aminotransferases; Birth Weight; Cesarean Section; Eclampsia; Female; Fetal Death; Headach | 1999 |
Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Creatinine; Female; HELLP Syndrome; Humans; L-Lac | 1999 |